Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-02-29

Posted on February 29, 2024August 12, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-02-29

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hyundai Motor will hold an Investor Relations (IR) event in Seoul on March 7, 2024, targeting major overseas institutional investors to present Q4 2023 business performance and address key investor interests.

📊 [Key Disclosure Content & Financial Highlights]

1. IR Event Details

  • Date & Time: March 7, 2024, at 09:00 (KST)
  • Location: Conrad Seoul
  • Target Audience: Major overseas institutional investors
  • Sponsoring Institution: Citi Securities

2. Purpose & Meeting Format

  • Purpose: To enhance investor understanding of the company through conference participation
  • Format: Investor meetings (One-on-One and small group)

3. Key Presentation Topics & Presentation Material

  • Main Topics: Overview of Q4 2023 business performance and key investor interest matters
  • IR Material Publication Date & Time: March 7, 2024
  • Website: Official Website (www.hyundai.com)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of IR Presentation Material Publication

Checking whether the presentation material is published according to the schedule on the day of the IR event is important for understanding the business performance details and topics presented to overseas institutional investors. The published presentation materials can be confirmed through Hyundai Motor’s official website and subsequent IR disclosures.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on officially submitted data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided strictly for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Jeju Semiconductor (080220) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Companies) / 2024-02-28
Next Post: [Disclosure] Jeju Semiconductor (080220) – Decision on Calling of General Shareholders Meeting / 2024-02-29

Related Posts

[Disclosure] HPSP (403870) – Change of Market Segment Classification / 2025-04-30 Semiconductors
[Disclosure] Hanwha Aerospace (012450) – (Correction) Investor Relations (IR) Event / 2024-07-29 Disclosures
[Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2025-03-21 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-03-03 Semiconductors
[Disclosure] Hanwha Aerospace (012450) – Organization of Investor Relations Event / 2026-01-20 Disclosures
[Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement for Human Hyaluronidase Core Technology (ALT-B4) / 2025-03-17 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations (Correction) / 2026-08-10August 10, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme